Rayner to Announce Launch of RayPRO+ Digital Health Platform at the ESCRS

Rayner announced the global launch of RayPRO+ at the upcoming ESCRS 2022 congress in Milan. RayPRO is Rayner’s proprietary mobile app and web-based digital platform that proactively collects a blend of patient reported outcomes (PROs) over 3 years. RayPRO+ has the added ability to record patient outcomes with non-Rayner IOLs, creating a more complete picture for surgeons including comparative data. The app features easy-to-understand reports presented in real-time via the RayPRO+ dashboard that can be accessed anywhere anytime, according to Rayner.

“Since launching RayPRO in 2019, we have been closely listening to feedback from surgeons which has resulted in numerous enhancements to the platform," Rayner CEO Tim Clover said in a company news release. "RayPRO+ is by far the biggest evolution to date and has been facilitated by Wolffsohn Research, our software development partner led by Professor James Wolffsohn. I have long believed that decisions within ophthalmology should be based upon large data sets, which is why I’m excited to now offer RayPRO+ to surgeons who are interested in collecting Big Data about their patients’ outcomes, but who may not be current or exclusive users of Rayner IOLs.”

Accompanying the company’s Raytrace online lens calculator, RayPRO+ will become Rayner’s flagship digital solution.

All surgeons who register for RayPRO+ during the ESCRS congress will be given 6 months free access, according to Rayner. RayPRO+ is free for Rayner IOL users and has a £49.99 monthly subscription fee for non-Rayner IOL users.

Surgeons are invited to experience RayPRO+ for themselves by visiting the Rayner booth (C11, Hall 4) at the ESCRS Congress in Milan.

More information can be found at www.rayner.com/RayPRO.